To date, research and development (R&D) within the pharmaceutical industry has been dominated by a developed-market perspective. But as emerging markets change Pharma’s worldview, it’s time for drugmakers to fundamentally rethink how R&D is done.

Drug Discovery and Development, Drug Discovery
Editor(s) - Mukund S Chorghade

This two-volume set provides a comprehensive account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners. The first volume of this set thoroughly describes conceptualizing a drug, creating a library of candidates for testing, screening those candidates for in vitro and in vivo activity, conducting and analyzing the results of clinical trials, and revising the drug as necessary.

Cancer Clinical Trials: Proactive Strategies
Editor(s) - Stanley P L Leong

Clinical trials remain the most important vehicle for improving the care of cancer patients. This text presents the fundamental components and challenges involving clinical investigations. Leading experts discuss the critical issues covering the spectrum of important topics from planning to application.

RCTs of head-to-head comparisons of statins with other drugs are more likely to report results and conclusions favoring the sponsor's product compared to the comparator drug.

Gearing up for a global gravity shift -
growth, risk and learning in the Asia pharmaceutical market